<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The reactivity pattern of the murine monoclonal antibody (MoAb) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCS</z:e>-2 was tested on a panel of 724 cases of <z:hpo ids='HP_0001909'>leukemia</z:hpo>-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCS</z:e>-2 was positive in 178/185 (96%) cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (<z:e sem="disease" ids="C0026998" disease_type="Neoplastic Process" abbrv="">FAB M1</z:e>-3), 10/10 cases of AMMol/AMoL (<z:e sem="disease" ids="C0023479" disease_type="Neoplastic Process" abbrv="AMML">FAB M4</z:e>/5), 42/45 (93%) cases of <z:mp ids='MP_0005481'>CML</z:mp>, 1/1 case of CMoL, 37/38 (97%) cases of <z:mp ids='MP_0005481'>CML</z:mp>-myeloid <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e>, 0/9 cases of <z:mp ids='MP_0005481'>CML</z:mp>-lymphoid <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>No positive staining was seen in 238 cases of T-CLL, <z:e sem="disease" ids="C0026948" disease_type="Neoplastic Process" abbrv="">mycosis fungoides</z:e>, SÃ¨zary-syndrome, B-CLL, hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> and T- and B-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> nor in 32 cases of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, Burkitt-<z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Null-ALL and immature T-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A positive expression was found in 8/110 cases of <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">cALL</z:e>, 1/6 cases of <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre B-ALL</z:e> and 1/35 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Fifteen other MoAbs (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCS</z:e>-1, OKM1, My-1, Leu-M1, Leu-M3, CA-2-38, MY4, MY7, MY8, MY9, VIM-D2, VIM-D5, Mol, <z:chebi fb="0" ids="37238">Mo2</z:chebi>, 63D3) which are associated with the myelomonocytic cell lineages were tested by indirect immunofluorescence on 60 or more patients (62-149 cases) </plain></SENT>
<SENT sid="5" pm="."><plain>A wide variability in the frequency of positivity was seen for the panel of cases studied and for the blast cell populations per individual samples: 21-96% of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cases (<z:e sem="disease" ids="C0026998" disease_type="Neoplastic Process" abbrv="">FAB M1</z:e>-3) and 31-100% of the AMMoL/AMoL cases (<z:e sem="disease" ids="C0023479" disease_type="Neoplastic Process" abbrv="AMML">FAB M4</z:e>/5) were positive for the various MoAbs </plain></SENT>
<SENT sid="6" pm="."><plain>None of the analysed MoAbs stained only myelocytic or only monocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo>, but a certain degree of preference for the monocytic variants was noted for Leu-M3, CA-2-38, MY4, VIM-D2, <z:chebi fb="0" ids="37238">Mo2</z:chebi> and 63D3 </plain></SENT>
<SENT sid="7" pm="."><plain>The detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCS</z:e>-2 on immature ALL blast cells might indicate a coexpression of lymphoid and myeloid markers on very immature cells, or an abnormal gene expression by malignant cells, or the identification of a so far undetected subclass of <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> </plain></SENT>
</text></document>